FindTrial
Sign In

To Study levels of blood cholesterol, lipids in patients with Cirrhosis of Liver

To Study the changes in Lipid Profile in patients with Cirrhosis of Liver : An observational prospective study in a tertiary care teaching hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/01/048894
Enrollment
120
Registered
2023-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2023-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K746- Other and unspecified cirrhosis ofliver

Interventions

None listed

Sponsors

PCMC PGI YCM Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: liver cirrhosis patients were taken as Group A and apparently healthy age- and sex-matched patients as Group B.

Exclusion criteria

Exclusion criteria: The patients were cholesterol-lowering medicines within the previous 30 days. Patients with a history of other medical illnesses which may influence the serum lipid level such as diabetes mellitus, hypertension, chronic smoker, nephrotic syndrome, and/or thyroid dysfunctions were excluded from the study from both Group A and Group B. All patients who have refused to give consent for the study

Design outcomes

Primary

MeasureTime frame
There are changes in Lipid Profile in patients with Cirrhosis of LiverTimepoint: At baseline after Inclusion criteria satisfied—

Secondary

MeasureTime frame
There is significant decrease in serum total cholesterol, LDL cholesterol, and serum triglyceride levels in liver cirrhosis patients (cases) compared to control patientsTimepoint: At baseline after Inclusion criteria satisfied—

Countries

India

Contacts

Public ContactDr Pathak Niranjan Pandurang

PCMC PGI YCM Hospital

nrnjnpats@gmail.com9730490292

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026